Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

The Latest
Ansley Kahn
Research Roundup: Metagenomics sequencing, combinations of antibodies that suppress HIV, and a partnership to reduce child deaths from AMR

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Recent

PATH/Evelyn Hockstein
Research Roundup: Ebola vaccine hurdles, SDG financing, blocking malaria transmission, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Aaron Joel Santos
Research Roundup: hookworm vaccine trial, Grand Challenges turns ten, NIH funding for Ebola and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Heng Chivoan
Research Roundup: Intellectual property awards, FDA priorities, Australia R&D, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Satvir Malhotra
Research Roundup: R&D in the post-2015 agenda, TB vaccines, the Global Innovation Fund, intellectual property, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Making the case for research and innovation for health in the post-2015 development agenda

In this guest post, Claire Wingfield—product development policy officer at PATH—writes about a new paper exploring why research and development (R&D) of high-priority health tools for diseases and conditions affecting low- and middle-income countries (LMICs) should be a critical component of the post-2015 development agenda.

PATH
Read More
PATH
Research Roundup: UNGA, public-private partnerships, new executive orders, neglected disease R&D grants, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Over 150 organizations and individuals urge UN to keep health R&D at the heart of the post-2015 agenda

With the 69th session of the United Nations (UN) General Assembly opening this week in New York and the global community debating how best to refine the post-2015 development agenda, over 150 organizations and individuals signed a petition to UN Secretary General Ban Ki-moon and Member States urging the UN to keep the research, development, and delivery of new and improved health tools at the heart of the post-2015 development agenda.

Read More
Research Roundup: Congressional priorities, new HIV antibody, biomedical research funding, TB drug trial results, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Recess is over: What Congress should act on now

After a five week recess, members of Congress returned to their Capitol Hill offices on Tuesday night.

GHTC
Read More
PATH/Dan Chang
Research Roundup: Funding global health R&D, the neglected disease pipeline, Ebola vaccines, FDA approvals, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Why invest in R&D for HIV, TB and malaria? Because it’s good for global health, and good for Europe

In this post, Eoghan Walsh—communications officer at Deutsche Stiftung Weltbevoelkerung (DSW)—writes about the need for Europe to increase financial and political support for efforts aimed at creating new ways to tackle diseases such as HIV/AIDS, tuberculosis (TB) and malaria.

Read More
PATH/Aaron Joel Santos
Research Roundup: MDGs, TB vaccines, impactful innovations, budget trackers, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Evelyn Hockstein
Research Roundup: New TB drugs, the Global Development Lab, licensing agreements, emergency Ebola research, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
New TB drug bedaquiline: Weighing the benefits against the risks

Earlier this month, advocates from the Community Research Advisors Group (CRAG)—an international, community-based advisory body working to ensure the engagement of affected communities in tuberculosis (TB) research conducted by the Centers for Disease Control and Prevention (CDC) —published an article in The Lancet offering a community perspective on the use of the drug bedaquiline to treat drug-resistant and drug-susceptible TB.

Read More
PATH/Eric Becker
Research Roundup: New malaria drugs, chikungunya vaccines, Africa Leaders Summit, preterm births coalition, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
A new era for malaria treatment

In this post, PATH Vice President of Product Development, David Kaslow, writes about the first-ever shipment of semisynthetic artemisinin (ssART)—a new type of malaria treatment that marks a significant milestone in the fight against malaria.

Read More
PATH/Gabe Bienczycki
Four key takeaways from the Africa Leaders Summit

As the first-ever US-Africa Leaders Summit came to a close last week, it was clear that the energy around the partnerships between the United States and African nations are strong and building momentum.

GHTC
Read More
PATH/Evelyn Hockstein
Research Roundup: Saving Lives at Birth, US-Africa Leaders Summit, possible Ebola vaccine, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
A challenge that sparks innovation and saves lives

“Innovation can’t take place if people say we don’t need new tools,” said Partners in Health Co-founder Paul Farmer at an event sponsored by the Saving Lives at Birth: A Grand Challenge for Development program last week in Washington, DC.

GHTC
Read More
Breastfeeding goes high tech

Breastfeeding has served as the primary method for a mother to feed her infant since the dawn of humanity, but could it also be a way for her to administer life-saving medicines to her baby?

Read More